These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779 [TBL] [Abstract][Full Text] [Related]
5. Luteolin Improves Perivascular Adipose Tissue Profile and Vascular Dysfunction in Goto-Kakizaki Rats. Queiroz M; Leandro A; Azul L; Figueirinha A; Seiça R; Sena CM Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948468 [TBL] [Abstract][Full Text] [Related]
6. Short-term pharmacological activation of Nrf2 ameliorates vascular dysfunction in aged rats and in pathological human vasculature. A potential target for therapeutic intervention. Angulo J; El Assar M; Sevilleja-Ortiz A; Fernández A; Sánchez-Ferrer A; Romero-Otero J; Martínez-Salamanca JI; La Fuente JM; Rodríguez-Mañas L Redox Biol; 2019 Sep; 26():101271. PubMed ID: 31302408 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery. Matsumoto T; Ishida K; Taguchi K; Kobayashi T; Kamata K Peptides; 2009 Sep; 30(9):1729-34. PubMed ID: 19540892 [TBL] [Abstract][Full Text] [Related]
8. Natural therapeutic magnesium lithospermate B potently protects the endothelium from hyperglycaemia-induced dysfunction. Kim SH; Kim SH; Choi M; Lee Y; Kim YO; Ahn DS; Kim YH; Kang ES; Lee EJ; Jung M; Cho JW; Williams DR; Lee HC Cardiovasc Res; 2010 Sep; 87(4):713-22. PubMed ID: 20299332 [TBL] [Abstract][Full Text] [Related]
9. Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats. Nemoto S; Kobayashi T; Taguchi K; Matsumoto T; Kamata K Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2383-94. PubMed ID: 21926342 [TBL] [Abstract][Full Text] [Related]
10. Hypoglycaemic and Antioxidant Properties of Monteiro-Alfredo T; Oliveira S; Amaro A; Rosendo-Silva D; Antunes K; Pires AS; Teixo R; Abrantes AM; Botelho MF; Castelo-Branco M; Seiça R; Silva S; de Picoli Souza K; Matafome P Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445015 [TBL] [Abstract][Full Text] [Related]
11. Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen. Chang KC; Liang JT; Tsai PS; Wu MS; Hsu KL Br J Pharmacol; 2009 Aug; 157(8):1419-26. PubMed ID: 19681870 [TBL] [Abstract][Full Text] [Related]
12. Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats. Glaeser JD; Ju D; Tawackoli W; Yang JH; Salehi K; Stefanovic T; Kanim LEA; Avalos P; Kaneda G; Stephan S; Metzger MF; Bae HW; Sheyn D Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352698 [TBL] [Abstract][Full Text] [Related]
13. Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet. Sena CM; Louro T; Matafome P; Nunes E; Monteiro P; Seiça R Physiol Res; 2009; 58(2):203-209. PubMed ID: 18380531 [TBL] [Abstract][Full Text] [Related]